共 622 条
[1]
Kristinsson SY(2012)Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study Haematologica. Ferrata Storti Foundation 97 854-858
[2]
Tang M(2002)Relationship between CD4(+)/CD8(+) T cell ratio and T cell activation in multiple myeloma: reference to IL-16 Leuk Res 26 705-711
[3]
Pfeiffer RM(2005)High Th1/Th2 ratio in patients with multiple myeloma Leuk Res 29 135-140
[4]
Björkholm M(2015)The cellular immune system in myelomagenesis: NK cells and T cells in the development of myeloma [corrected] and their uses in immunotherapies Blood Cancer J 5 e306-384
[5]
Goldin LR(1998)The expression of T cell related costimulatory molecules in multiple myeloma Leuk Lymphoma 31 379-5063
[6]
Blimark C(2014)Immunological dysregulation in multiple myeloma microenvironment Biomed Res Int 2014 198539-807
[7]
Koike M(2015)Immunomodulatory molecule PD-L1 is expressed on malignant plasma cells and myeloma-propagating pre-plasma cells in the bone marrow of multiple myeloma patients Blood Cancer J 5 e285-1400
[8]
Sekigawa I(2013)Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: longterm results of the EBMT-NMAM2000 study Blood 121 5055-687
[9]
Okada M(2015)Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma Bone Marrow Transplant 50 802-13
[10]
Matsumoto M(2013)Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation Bone Marrow Transplant 48 1395-488